Literature DB >> 16362662

Habituation of single CO2 laser-evoked responses during interictal phase of migraine.

Marina de Tommaso1, Giuseppe Libro, Marco Guido, Luciana Losito, Paolo Lamberti, Paolo Livrea.   

Abstract

A reduced habituation of averaged laser-evoked potential (LEP) amplitudes was previously found in migraine patients. The aim of the present study was to assess the habituation of single LEP responses and pain sensation during the interictal phase in migraine patients. Fourteen migraine patients were compared with ten control subjects. The pain stimulus was laser pulses, generated by CO2 laser, delivered to right supraorbital zone. Patients were evaluated during attack-free conditions. The LEP habituation was studied by measuring the changes of LEP amplitudes across and within three consecutive repetitions of 21 non-averaged trials. In migraine patients the N2-P2 wave amplitudes did not show a tendency toward habituation across and, above all, within the three repetitions. Anomalous behaviour of nociceptive cortex during the interictal phase of migraine may predispose patients to headache occurrence and persistence.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16362662      PMCID: PMC3452042          DOI: 10.1007/s10194-005-0183-0

Source DB:  PubMed          Journal:  J Headache Pain        ISSN: 1129-2369            Impact factor:   7.277


  18 in total

1.  Deficient pain modulatory systems in patients with mild traumatic brain and chronic post-traumatic headache: implications for its mechanism.

Authors:  Ruth Defrin; Miri Riabinin; Yelena Feingold; Shaul Schreiber; Chaim G Pick
Journal:  J Neurotrauma       Date:  2015-01-01       Impact factor: 5.269

2.  The dynamics of pain: evidence for simultaneous site-specific habituation and site-nonspecific sensitization in thermal pain.

Authors:  Marieke Jepma; Matt Jones; Tor D Wager
Journal:  J Pain       Date:  2014-04-24       Impact factor: 5.820

3.  Painful heat reveals hyperexcitability of the temporal pole in interictal and ictal migraine States.

Authors:  E A Moulton; L Becerra; N Maleki; G Pendse; S Tully; R Hargreaves; R Burstein; D Borsook
Journal:  Cereb Cortex       Date:  2010-06-18       Impact factor: 5.357

Review 4.  Cortical pain processing in migraine.

Authors:  Gianluca Coppola; Vincenzo Parisi; Antonio Di Renzo; Francesco Pierelli
Journal:  J Neural Transm (Vienna)       Date:  2019-10-09       Impact factor: 3.575

5.  The genetic influence on the cortical processing of experimental pain and the moderating effect of pain status.

Authors:  Helen Vossen; Gunter Kenis; Bart Rutten; Jim van Os; Hermie Hermens; Richel Lousberg
Journal:  PLoS One       Date:  2010-10-26       Impact factor: 3.240

Review 6.  [Contact heat evoked potentials for the evaluation of pain pathways].

Authors:  C L Seifert; D Nitzsche; M Valet; T R Tölle; T Sprenger
Journal:  Nervenarzt       Date:  2008-08       Impact factor: 1.214

Review 7.  Altered processing of sensory stimuli in patients with migraine.

Authors:  Marina de Tommaso; Anna Ambrosini; Filippo Brighina; Gianluca Coppola; Armando Perrotta; Francesco Pierelli; Giorgio Sandrini; Massimiliano Valeriani; Daniele Marinazzo; Sebastiano Stramaglia; Jean Schoenen
Journal:  Nat Rev Neurol       Date:  2014-02-18       Impact factor: 42.937

8.  Detection and discrimination of flicker contrast in migraine.

Authors:  Olivera Karanovic; Michel Thabet; Hugh R Wilson; Frances Wilkinson
Journal:  Cephalalgia       Date:  2011-04       Impact factor: 6.292

9.  Topiramate modulates habituation in migraine: evidences from nociceptive responses elicited by laser evoked potentials.

Authors:  Laura Di Clemente; Francesca Puledda; Antonella Biasiotta; Alessandro Viganò; Edoardo Vicenzini; Andrea Truini; Giorgio Cruccu; Vittorio Di Piero
Journal:  J Headache Pain       Date:  2013-03-12       Impact factor: 7.277

Review 10.  Habituation and sensitization in primary headaches.

Authors:  Gianluca Coppola; Cherubino Di Lorenzo; Jean Schoenen; Francesco Pierelli
Journal:  J Headache Pain       Date:  2013-07-30       Impact factor: 7.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.